|
| 32761455 | Patterns of Ciliation and Ciliary Signaling in Cancer. | Reviews of Physiology Biochemistry and Pharmacology | 2023 |
| 37745612 | Trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer growth and immune suppression via phospholipid scramblase anoctamin 6 (ANO6). | | 2023 |
| 38001126 | Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer. | NPJ Genom Med | 2023 |
| 37095444 | Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing. | BMC Genomics | 2023 |
| 36711552 | Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry. | | 2023 |
| 36711508 | Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry. | | 2023 |
| 37398283 | Musashi-2 (MSI2) regulation of DNA damage response in lung cancer. | | 2023 |
| 37452870 | Intrapancreatic fat, pancreatitis, and pancreatic cancer. | | 2023 |
| 37430226 | Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing. | BMC Genomics | 2023 |
| 37542051 | Loss of Pkd1 limits susceptibility to colitis and colorectal cancer. | | 2023 |
| 35338148 | Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers. | Nat Commun | 2022 |
| 35525475 | A retrospective evaluation of a decade of Gene Wiki Reviews and their impact. | Gene | 2022 |
| 36108051 | H2-gamendazole: a new therapeutic lead for the treatment of polycystic kidney disease. | | 2022 |
| 36165728 | Aurora Kinases as Therapeutic Targets in Head and Neck Cancer. | Cancer journal (Sudbury, Mass.) | 2022 |
| 35491653 | Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer. | Clinical Cancer Research | 2022 |
| 35410460 | NEDD9 sustains hexokinase expression to promote glycolysis. | Oncogenesis | 2022 |
| 36053203 | Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. | J Natl Cancer Inst | 2022 |
| 35536216 | Delineating the RAS Conformational Landscape. | Cancer Res | 2022 |
| 35532818 | The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors. | Cellular and Molecular Life Sciences | 2022 |
| 34302809 | HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression. | Journal of Biological Chemistry | 2021 |
| 34237057 | Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression. | PLoS ONE | 2021 |
| 34006524 | Restrains Autophagy to Limit Growth of Early Stage Non-Small Cell Lung Cancer. | Cancer Research | 2021 |
| 34045230 | Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models. | Molecular Cancer Therapeutics | 2021 |
| 34202748 | Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies. | Cancers | 2021 |
| 33723247 | Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC). | Oncogenesis | 2021 |
| 32782288 | Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer. | Scientific Reports | 2020 |
| 32012873 | Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer. | Cancers (Basel) | 2020 |
| 32178823 | RNA interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attack. | Methods in Enzymology | 2020 |
| 31830556 | Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease. | Cellular Signalling | 2020 |
| 32165095 | Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. | European urology oncology | 2020 |
| 31981981 | Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD). | eBioMedicine | 2020 |
| 32976774 | Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer. | Cancer Cell | 2020 |
| 32524559 | Identification of the KRIT1 Protein by LexA-Based Yeast Two-Hybrid System. | Methods in Molecular Biology | 2020 |
| 32732223 | X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis. | Clinical Cancer Research | 2020 |
| 31051112 | Disease-Associated Genetic Variation in Human Mitochondrial Protein Import. | American Journal of Human Genetics | 2019 |
| 31822657 | PPP2R2A prostate cancer haploinsufficiency is associated with worse prognosis and a high vulnerability to B55α/PP2A reconstitution that triggers centrosome destabilization. | Oncogenesis | 2019 |
| 31234819 | An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion. | BMC Cancer | 2019 |
| 30867219 | Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs. | Clinical Cancer Research | 2019 |
| 30755439 | Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck. | Clin Cancer Res | 2019 |
| 30809247 | Microscopy-Based Automated Live Cell Screening for Small Molecules That Affect Ciliation. | Frontiers in Genetics | 2019 |
| 31484422 | Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC). | Cancers | 2019 |
| 30680959 | Interaction of germline variants in a family with a history of early-onset clear cell renal cell carcinoma. | Mol Genet Genomic Med | 2019 |
| 31427573 | Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients. | Nat Commun | 2019 |
| 31254157 | Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer. | Breast Cancer Research and Treatment | 2019 |
| 29773902 | NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice. | Oncogene | 2018 |
| 29945886 | Molecular mechanisms of the preventable causes of cancer in the United States. | Genes Dev | 2018 |
| 29401581 | Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD). | FASEB Journal | 2018 |
| 29802351 | Ciliary signalling in cancer. | Nature Reviews Cancer | 2018 |
| 27863405 | Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin. | Oncotarget | 2017 |
| 28453558 | Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model. | PLoS ONE | 2017 |